Publications & information
Live stock price
Click here for live stock price
OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris
- ISIN: FR0012127173
- Ticker: OSE
- Type of listing: continuous
- Number of outstanding shares: 14,967,012 shares as of December 31, 2019
- Eligible to Long-Only Deferred Settlement Service
|26 March 2020||Publication of the 2019 consolidated accounts|
|16 June 2020||Annual General Meeting|
|17 September 2020||Publication of 2020 half-year results|
Press releases are distributed after the close of the stock market.
This financial calendar is for indicative purposes only and OSE Immunotherapeutics could change its publication dates should it deem it necessary.
Analysts following OSE Immunotherapeutic
H.C. Wainwright & CO. (US) Swayampakula RamakanthE-MAIL
LifeSci Capital (US) Jacques VillefrancE-MAIL
Edison (UK) Jonas PeciulisE-MAIL
Kepler Cheuvreux (FR) Thomas LandemaineE-MAIL
Invest Securities (FR) Martial DescouturesE-MAIL
Portzamparc (FR) Christophe DombuE-MAIL
Bryan, Garnier & Co Eric Le BerrigaudE-MAIL
Gilbert Dupont Jamila El Bougrini, Guillaume Cuvillier
Any opinions, estimates or forecasts regarding OSE Immunotherapeutics performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of OSE Immunotherapeutics or its management.